Clinical Trial Update: Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of paclitaxel and celecoxib for recurrent or persistent platinum-resistant ovarian epithelial cancer or prim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | Status: TERMINATED